The effects of β-adrenoceptor antagonists on proinflammatory cytokine concentrations after subarachnoid hemorrhage in rats

Anesthesia and Analgesia

Volumn 108, Issue 1, 2009, Pages 288-295

  Kato, Haruto ^a   Kawaguchi, Masahiko ^a   Inoue, Satoki ^a   Hirai, Katsuji ^a   Furuya, Hitoshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUTOXAMINE; INTERLEUKIN 6; METOPROLOL; PROPRANOLOL; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BETA 2 ADRENERGIC RECEPTOR; NEUROPROTECTIVE AGENT;

ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MODEL; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; RAT; SHAM PROCEDURE; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; ANIMAL; BLOOD; DRUG ANTAGONISM; IMMUNOLOGY; METABOLISM; SPRAGUE DAWLEY RAT; TIME;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BUTOXAMINE; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; METOPROLOL; NEUROPROTECTIVE AGENTS; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-2; SUBARACHNOID HEMORRHAGE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58749103521     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318187bb93     Document Type: Article

References (27)

1. Hendryk S, Jarzab B, Josko J. Increase of the IL-1- and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuroendocrinol Lett 2004;25:141-7
2. Mathiesen T, Edner G, Ulfarsson E, Andersson B. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor- following subarachnoid hemorrhage. J Neurosurg 1997;87:215-20
3. Macmillan CS, Grant IS, Andrews PJ. Pulmonary and cardiac sequelae of subarachnoid haemorrhage: time for active management? Intensive Care Med 2002;28:1012-23
4. Norris JG, Benveniste EN. Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J Neuroimmunol 1993;45:137-46
5. Ohtsuka T, Hamada M, Saeki H, Ogimoto A, Hiasa G, Hara Y, Shigematsu Y, Hiwada K. Comparison of effects of carvedilol versus metoprolol on cytokine levels in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2002;89:996-9
6. Tatli E, Kurum T. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy. Can J Cardiol 2005;21:344-8
7. Prunell GF, Mathiesen T, Svendgaard NA. A new experimental model in rats for study of the pathophysiology of subarachnoid hemorrhage. Neuroreport 2002;13:2553-6
8. Prunell GF, Mathiesen T, Diemer NH, Svendgaard NA. Experimental subarachnoid hemorrhage: subarachnoid blood volume, mortality rate, neuronal death, cerebral blood flow, and perfusion pressure in three different rat models. Neurosurgery 2003;52:165-76
9. Gaetani P, Tartara F, Pignatti P, Tancioni F, Rodriguez y Baena R, De Benedetti F. Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res 1998;20:337-42
10. Osuka K, Suzuki Y, Tanazawa T, Hattori K, Yamamoto N, Takayasu M, Shibuya M, Yoshida J. Interleukin-6 and development of vasospasm after subarachnoid haemorrhage. Acta Neurochir 1998;140:943-51
11. Kikuchi T, Okuda Y, Kaito N, Abe T. Cytokine production in cerebrospinal fluid after subarachnoid haemorrhage. Neurol Res 1995;17:106-8
12. Yatsushige H, Yamaguchi M, Zhou C, Calvert JW, Zhang JH. Role of c-Jun N-terminal kinase in cerebral vasospasm after experimental subarachnoid hemorrhage. Stroke 2005;36: 1538-43
13. Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schutt S, Fritzinger M, Horn P, Vajkoczy P, Kreisel S, Brunner J, Schmiedek P, Hennerici M. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry 2001;70:534-7
14. Cruickshank JM, Neil-Dwyer G. -blocker brain concentration in man. Eur J Clin Pharmacol 1985;28(suppl):21-3
15. Li B, Liao YH, Cheng X, Ge H, Guo H, Wang M. Effects of carvedilol on cardiac cytokines expression and remodeling in rat with acute myocardial infarction. Int J Cardiol 2006;111: 247-55
16. Prabhu SD, Chandrasekar B, Murray DR, Freeman GL. -adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 2000;101:2103-9
17. Woiciechowsky C, Schoning B, Stoltenburg-Didinger G, Stockhammer F, Volk HD. Brain-IL-1 triggers astrogliosis through induction of IL-6: inhibition by propranolol and IL-10. Med Sci Monit 2004;10:BR325-30
18. Maimone D, Cioni C, Rosa S, Macchia G, Aloisi F, Annunziata P. Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: synergism with IL-1 and TNF-. J Neuroimmunol 1993;47:73-81
19. Stover JF, Sakowitz OW, Schoning B, Rupprecht S, Kroppenstedt SN, Thomale UW, Woiciechowsky C, Unterberg AW. Norepinephrine infusion increases interleukin-6 in plasma and cerebrospinal fluid of brain-injured rats. Med Sci Monit 2003;9:BR382-8
20. Christensen JD, Hansen EW, Frederiksen C, Molris M, Moesby L. Adrenaline influences the release of interleulin-6 from murine pituicytes: role of 2-adrenoceptors. Eur J Pharmacol 1999;378:143-8
21. Frost RA, Nystrom GJ, Lang CH. Epinephrine stimulates IL-6 expression in skeletal muscle and C2C12 myoblasts: role of c-Jun NH2-terminal kinase and histone deacetylase activity. Am J Physiol Endocrinol Metab 2004;286:E809-17
22. Nakamura A, Johns EJ, Imaizumi A, Yanagawa Y, Kohsaka T. -2-adrenoceptor agonist suppresses renal tumor necrosis factor and enhances interleukin-6 gene expression induced by endotoxin. Nephrol Dial Transplant 2000;15:1928-34
23. Nakamura A, Johns EJ, Imaizumi A, Yanagawa Y, Kohsaka T. Modulation of interleukin-6 by -2-adrenoceptor in endotoxinstimulated renal macrophage cells. Kidney Int 1999;56:839-49
24. Yin F, Wang YY, Du JH, Li C, Lu ZZ, Han C, Zhang YY. Noncanonical cAMP pathway and p38 MAPK mediate -2-adrenergic receptor-induced IL-6 production in neonatal mouse cardiac fibroblasts. J Mol Cell Cardiol 2006;40:384-93
25. Kaan SK, Cho CH. Study of propranolol and its related adrenoceptor antagonists on changes of gastric electrical parameters induced by ethanol in rats. Pharmacology 1999;58:8-14
26. Suemaru K, Kawasaki H, Oishi R, Gomita Y, Tanizaki Y. Role of central nicotinic and --adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats. Naunyn Schmiedebergs Arch Pharmacol 1997;355:571-5
27. Irwin M, Hauger RL, Jones L, Provencio M, Britton KT. Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity. J Pharmacol Exp Ther 1990;255:101-7